Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) FCF Margin: 2010-2016

Historic FCF Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to -206,043.07%.

  • Tenax Therapeutics' FCF Margin was N/A to -206,043.07% in Q4 2016 from the same period last year, while for Dec 2016 it was -840.89%, marking a year-over-year change of. This contributed to the annual value of 64,395.65% for FY2024, which is 3979565.00% up from last year.
  • According to the latest figures from Q4 2016, Tenax Therapeutics' FCF Margin is -206,043.07%, which was down 396.90% from 69,399.23% recorded in Q2 2015.
  • Tenax Therapeutics' 5-year FCF Margin high stood at 69,399.23% for Q2 2015, and its period low was -206,043.07% during Q4 2016.
  • Its 2-year average for FCF Margin is -68,321.92%, with a median of -68,321.92% in 2015.
  • Examining YoY changes over the last 5 years, Tenax Therapeutics' FCF Margin showed a top increase of 3,820,107bps in 2012 and a maximum decrease of 2,576,416bps in 2012.
  • Quarterly analysis of 4 years shows Tenax Therapeutics' FCF Margin stood at -11,035.14% in 2012, then slumped by 204,633bps to -3,540.98% in 2013, then reached 69,399.23% in 2015, then reached -206,043.07% in 2016.
  • Its FCF Margin stands at -206,043.07% for Q4 2016, versus 69,399.23% for Q2 2015 and -3,540.98% for Q2 2013.